SonoScape Medical Corp.

Shenzhen Stock Exchange 300633.SZ

SonoScape Medical Corp. Gross Profit Margin for the year ending December 31, 2023: 69.41%

SonoScape Medical Corp. Gross Profit Margin is 69.41% for the year ending December 31, 2023, a 3.81% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

SonoScape Medical Corp. Gross Profit Margin for the year ending December 31, 2022 was 66.87%, a -0.77% change year over year.
SonoScape Medical Corp. Gross Profit Margin for the year ending December 31, 2021 was 67.38%, a 1.41% change year over year.
SonoScape Medical Corp. Gross Profit Margin for the year ending December 31, 2020 was 66.45%, a 1.78% change year over year.
SonoScape Medical Corp. Gross Profit Margin for the year ending December 31, 2019 was 65.28%, a -6.57% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shenzhen Stock Exchange: 300633.SZ

SonoScape Medical Corp.

CEO	Mr. Kunxiang Wu
IPO Date	April 7, 2017
Location	China
Headquarters	Shenzhen Software Park, 12
Employees	2,697
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Defense & Military Hardware & Electronics Plastics Robotics

Description

SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.

Key trends

Past 5 years